Chemeotherapy

Clinical trials for Chemeotherapy explained in plain language.

Never miss a new study

Get alerted when new Chemeotherapy trials appear

Sign up with your email to follow new studies for Chemeotherapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can immunotherapy plus chemo wipe out Triple-Negative breast cancer before surgery?

Disease control Completed

Researchers are testing whether adding the immunotherapy drug tislelizumab to standard TAC chemotherapy helps shrink triple-negative breast cancer before surgery. The trial enrolls 36 women with newly diagnosed triple-negative breast cancer. Participants receive six cycles of tis…

Matched conditions: CHEMEOTHERAPY

Phase 2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control

Last updated Sep 20, 2026 00:00 UTC

Chemeotherapy

Get alerted when new Chemeotherapy trials appear

Can immunotherapy plus chemo wipe out Triple-Negative breast cancer before surgery?